Ticker > Company >

Ambey Laboratories share price

Ambey Laboratories Ltd.

NSE: AMBEY SECTOR: Pesticides & Agrochemicals  3319   4   0

72.75
+1.25 (1.75%)
NSE: 09 Dec 03:47 PM

Price Summary

Today's High

₹ 75

Today's Low

₹ 71

52 Week High

₹ 97.2

52 Week Low

₹ 56.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

181.49 Cr.

Enterprise Value

210.75 Cr.

No. of Shares

2.49 Cr.

P/E

23.5

P/B

2.78

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  26.21

CASH

0.38 Cr.

DEBT

29.64 Cr.

Promoter Holding

69.9 %

EPS (TTM)

₹  3.1

Sales Growth

14.93%

ROE

52.08 %

ROCE

21.4%

Profit Growth

47.36 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year14.93%
3 Year13.8%
5 YearNA

Profit Growth

1 Year47.36%
3 Year-9.26%
5 YearNA

ROE%

1 Year52.08%
3 Year51.24%

ROCE %

1 Year21.4%
3 Year24.05%

Debt/Equity

1.4107

Price to Cash Flow

-14.02

Interest Cover Ratio

3.2399

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 69.90 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 51.2395% over the past 3 years.
  • Company has been maintaining healthy ROCE of 24.0494% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 37.7527 days.
  • The company has a high promoter holding of 69.9%.

 Limitations

  • The company has shown a poor profit growth of -9.26454858842395% for the Past 3 years.
  • The company has shown a poor revenue growth of 13.8020998844807% for the Past 3 years.
  • Company has negative cash flow from operations of -12.9421.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 81.74 84.6 104.82 120.47
Total Expenditure 71.99 74.25 96.97 111.39
Operating Profit 9.75 10.35 7.85 9.08
Other Income 0.68 0.51 2.77 1.59
Interest 4.11 3.06 2.09 2.42
Depreciation 3.22 2.97 2.96 2.52
Exceptional Items 0 0 -0.06 -0.3
Profit Before Tax 3.09 4.83 5.5 5.43
Tax -7.25 1.26 0.26 -2.29
Net Profit 10.34 3.57 5.24 7.72
Adjusted EPS (Rs.) 21.12 2.01 2.95 4.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.89 17.75 17.75 18.69
Total Reserves -12.76 1.32 1.39 12.82
Borrowings 29.6 14.31 13.2 16.32
Other N/C liabilities -6.27 -4.99 -0.39 -2.14
Current liabilities 21.92 21.58 21.63 31.04
Total Liabilities 37.39 49.96 53.59 76.74
Assets
Net Block 15.85 25.09 25.22 23.98
Capital WIP 0.95 0 0 3.84
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0.46 0.45 0.46 0.5
Other N/C Assets 0 0 0 0
Current Assets 20.13 24.42 27.92 48.42
Total Assets 37.39 49.96 53.59 76.74
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 3.09 4.83 5.5 5.43
Adjustment 7.24 5.98 4.79 4.37
Changes in Assets & Liabilities -8.12 -5.97 -0.85 -21.5
Tax Paid 0.53 0.77 0.61 -1.25
Operating Cash Flow 2.74 5.61 10.05 -12.94
Investing Cash Flow -1.17 -0.75 -3.69 -5.28
Financing Cash Flow -1.49 -5.08 -6.23 14.48
Net Cash Flow 0.09 -0.22 0.13 -3.74

Corporate Actions

Investors Details

PARTICULARS Sep 2024%
promoters 69.90
rishita gupta 1.40
sarina gupta 68.49
PARTICULARS Sep 2024%
investors 30.10
j4s venture fund-i 1.16
llp 0.27
nakshatra stressed assets... 1.65
sb opportunities fund i 1.19

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Ambey Laboratories Stock Price Analysis and Quick Research Report. Is Ambey Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Ambey Laboratories stock price today is Rs 72.75. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ambey Laboratories . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ambey Laboratories has a PE ratio of 23.5033760863244 which is high and comparatively overvalued .

  • Share Price: - The current share price of Ambey Laboratories is Rs 72.75. One can use valuation calculators of ticker to know if Ambey Laboratories share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ambey Laboratories has ROA of 11.8498 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ambey Laboratories has a Current ratio of 1.5598 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ambey Laboratories has a ROE of 52.0776 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Ambey Laboratories has a Debt to Equity ratio of 1.4107 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Ambey Laboratories has reported revenue growth of 14.9304 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Ambey Laboratories for the current financial year is 7.53938279126828 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ambey Laboratories is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ambey Laboratories is Rs 3.0953 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Ambey Laboratories in Ticker for free. Also, one can get the intrinsic value of Ambey Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Ambey Laboratories
X